BRCA2 and breast cancer: Previous studies have shown that MD is also a risk factor for BC in BRCA1 and BRCA2 PV carriers.24 25 Although BOADICEA considers the effect of MD in predicting BC risks, the number of women with MD data at baseline was too small (N=794) to allow for a model assessment, which is a major limitation of the study.